LEADER 02067nam  2200457   450 
001 9910317795403321
005 20230913183135.0
010   $a1-83881-683-6
010   $a1-78923-641-X
035   $a(CKB)4970000000100130
035   $a(NjHacI)994970000000100130
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/40328
035   $a(EXLCZ)994970000000100130
100   $a20221012d2018      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAdvances in pancreatic cancer /$fedited by Luis Rodrigo
210  1$aLondon, England :$cIntechOpen,$d[2018]
210  4$dİ2018
215   $a1 online resource (224 pages)
311   $a1-78923-640-1 
330   $aPancreatic cancer is a growing source of cancer-related death and has poor survival rates, which have not improved in the last few decades. Its high-mortality rate is attributed to pancreatic cancer biology, difficulty in early diagnosis, and lack of standardized international guidelines in assessing the pancreatic masses. This book aims to provide an update in the current state of play in pancreatic cancer diagnosis and to evaluate the benefits and limitations of the available diagnostic technology and therapy. The main modalities for diagnosis are imaging with HCT, MRI, USE, and PET. Some chapters review the improvements in the techniques used. Timely and accurate diagnosis of pancreatic cancer can lead to improve in the current poor outcome of this disease.
606   $aPancreas$xCancer
606   $aPancreatic Neoplasms
610   $aMedicine
610   $aGastrointestinal Oncology
610   $aOncology
610   $aHealth Sciences
615  0$aPancreas$xCancer.
615  2$aPancreatic Neoplasms.
676   $a616.99437
702   $aRodrigo$b Luis$c(Physician)
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910317795403321
996   $aAdvances in Pancreatic Cancer$92178730
997   $aUNINA